New at Prodigy Blog A collection of articles about our people, our capabilities, our industry, and everything in between. Del Doherty 4/1/26 Del Doherty 4/1/26 Muscle Relaxants and the Long Road Back to Work: Why Short-Term Relief Should Not Become Long Term Risk Read More Sarah Cirildo 3/18/26 Sarah Cirildo 3/18/26 Rotator Cuff Tears in Workers’ Compensation: Medications, Recovery, and Return to Work Read More Sarah Cirildo 3/11/26 Sarah Cirildo 3/11/26 How NSAIDs Fit into Evidence-Based Care for Acute Work Injuries Read More Del Doherty 8/22/25 Del Doherty 8/22/25 Gabapentin – The Good, the Bad, and the Overprescribed Read More Del Doherty 6/8/25 Del Doherty 6/8/25 Symbravo for Migraine: Clinical Relief for Patients or Patent Extension Strategy (Pain for Payers)? Read More Del Doherty 2/7/25 Del Doherty 2/7/25 A Non-Opioid Game Changer: Meet Journavx™ Read More Older Posts
Del Doherty 4/1/26 Del Doherty 4/1/26 Muscle Relaxants and the Long Road Back to Work: Why Short-Term Relief Should Not Become Long Term Risk Read More
Sarah Cirildo 3/18/26 Sarah Cirildo 3/18/26 Rotator Cuff Tears in Workers’ Compensation: Medications, Recovery, and Return to Work Read More
Sarah Cirildo 3/11/26 Sarah Cirildo 3/11/26 How NSAIDs Fit into Evidence-Based Care for Acute Work Injuries Read More
Del Doherty 8/22/25 Del Doherty 8/22/25 Gabapentin – The Good, the Bad, and the Overprescribed Read More
Del Doherty 6/8/25 Del Doherty 6/8/25 Symbravo for Migraine: Clinical Relief for Patients or Patent Extension Strategy (Pain for Payers)? Read More